February 11, 2026

Genetic link between type 2 diabetes and high blood pressure uncovered

February 11, 2026 / Research update / InnovateMed Author / type 2 diabetes

by University of Surrey Editors’ notes The GIST Add as preferred source Study overview. Credit: Nature Communications (2026). DOI: 10.1038/s41467-025-67449-2 Type 2 diabetes and high blood pressure share a genetic link, according to new research from the University of Surrey, U.K., and the Université de Lille, France. In a large-scale study, scientists examined genetic data linked to type […]

Genetic link between type 2 diabetes and high blood pressure uncovered Read More »

Shorter treatment regimens are safe options for preventing active tuberculosis, study finds

February 11, 2026 / Research update / InnovateMed Author / active tuberculosis

by Public Library of Science edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Rocinha favela, Rio de Janeiro, Brazil. A site of the study. Credit: Beatriz Kohler (CC-BY 4.0, creativecommons.org/licenses/by/4.0/) A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage of patients

Shorter treatment regimens are safe options for preventing active tuberculosis, study finds Read More »

Immunity against common virus leveraged against pancreatic cancer

February 11, 2026 / Research update / InnovateMed Author / pancreatic cancer

by Miles Martin, University of California – San Diego Editors’ notes The GIST Add as preferred source A test tumor from a CMV-infected mouse, treated with CMV peptides. Pink represents cell death. Credit: UC San Diego Health Sciences Researchers at the University of California San Diego have discovered a promising new treatment approach for pancreatic cancer,

Immunity against common virus leveraged against pancreatic cancer Read More »

Tiny one- to three-base RNAs could help stop autoimmune inflammation, study suggests

February 11, 2026 / Research update / InnovateMed Author / autoimmune inflammation

by Rob Clancy, Hudson Institute of Medical Research Editors’ notes The GIST Add as preferred source Natural TLR7 antagonism. Credit: Nature Immunology (2026). DOI:10.1038/s41590-026-02429-2 https://www.nature.com/articles/s41590-026-02429-2 RNA-based medicine is about to take a huge leap forward thanks to the discovery of extremely short RNA fragments with important anti-inflammatory properties. Professor Michael Gantier’s latest research, published in Nature Immunology, builds on the Nobel

Tiny one- to three-base RNAs could help stop autoimmune inflammation, study suggests Read More »

Combination treatment may slow disease progression in advanced sarcoma

February 11, 2026 / Research update / InnovateMed Author / sarcoma

by Melissa Rohman, Northwestern University Editors’ notes The GIST Add as preferred source Histopathology of leiomyosarcoma. Credit: Wikimedia Commons / CC BY-SA 4.0 An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology. “These findings support the combination as a

Combination treatment may slow disease progression in advanced sarcoma Read More »

Adult survivors of childhood cancer may be at higher risk for meningiomas

February 11, 2026 / Clinical Practice / InnovateMed Author / childhood cancer

by UT Southwestern Medical Center Editors’ notes The GIST Add as preferred source Cumulative Incidence of Subsequent Meningiomas for All Survivors, Dose of Cranial Radiation, Age at Primary Cancer Diagnosis, Female vs Male, Primary Cancer Diagnosis, and Diagnostic Era. Credit: JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.2025.48715 Certain chemotherapies are associated with an increased long-term risk of subsequent tumors in

Adult survivors of childhood cancer may be at higher risk for meningiomas Read More »

Rejuvenating neurons restores learning and memory in mice

February 11, 2026 / Research update / InnovateMed Author / memory

by Ecole Polytechnique Federale de Lausanne Editors’ notes The GIST Add as preferred source Partial reprogramming of engram cells rescues age-related cellular hallmarks and memory. Credit: Neuron (2026). DOI: 10.1016/j.neuron.2025.11.028 Age-related memory decline and neurodegenerative diseases like Alzheimer’s are often thought of as irreversible. But the brain is not static; neurons continually adjust the strength of their connections,

Rejuvenating neurons restores learning and memory in mice Read More »

Investigating the use of a common vitamin to treat the aggressive brain cancer glioblastoma

February 11, 2026 / Research update / InnovateMed Author / brain cancer glioblastoma

by University of Calgary Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Edward (Ed) Waldner had no idea why he didn’t feel well, but he knew he didn’t feel like himself. At 55 years of age, he felt exhausted all the time. It didn’t seem to matter how hard he had worked

Investigating the use of a common vitamin to treat the aggressive brain cancer glioblastoma Read More »

Vaccines causing ‘turbo cancer’? How fake science is spreading online

February 11, 2026 / Patient education / InnovateMed Author / cancer

by Marc Fleischmann Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Since the start of the coronavirus pandemic, claims that vaccines can cause severe disease have been widespread on social media, with skeptics raising the alarm about what they call “turbo cancer.” Recently, the anti-vaccine scene has been referring to a

Vaccines causing ‘turbo cancer’? How fake science is spreading online Read More »

What is atrial fibrillation and how is it treated?

February 11, 2026 / Patient education / InnovateMed Author / atrial fibrillation

by Mike Stobbe edited by Andrew Zinin Editors’ notes The GIST Add as preferred source Dr. Daniel Moore poses for The Associated Press Feb. 2, 2026, in Coppell, Texas. Credit: AP Photo/Julio Cortez Daniel Moore was about 30 the first time it happened. At the end of a long, hot, stressful day, he chugged an ice-cold

What is atrial fibrillation and how is it treated? Read More »